Saito Hiroaki, Abubakar Aminu Kende, Ozaki Akihiko, Hori Daisuke, Murakami Michio, Kaneda Yudai, Tsubokura Masaharu, Tabuchi Takahiro
Department of Radiation Health Management, Fukushima Medical University, Fukushima, Japan.
Department of Internal Medicine, Soma Central Hospital, Soma, Japan.
Cancer Med. 2025 Apr;14(8):e70859. doi: 10.1002/cam4.70859.
Maintaining a high participation rate is crucial for effective colorectal cancer (CRC) screening. The COVID-19 pandemic placed a significant burden on healthcare facilities, which hindered CRC screening efforts. However, the effects of the prolonged pandemic on CRC screening remain unclear.
We analyzed data from the Japan COVID-19 and Society Internet Survey in September 2021 and 2022 to examine CRC screening participation over the past year. We also evaluated the association between CRC screening participation in 2022 and the participation status, future screening intentions, background characteristics, and anxiety about COVID-19 measured using the fear of coronavirus disease 2019 scale (FVC-19S) from the 2021 survey..
Of the 13,261 respondents, 40.5% reported undergoing CRC screening in 2021, while 48.7% did so in 2022. Multivariable Poisson regression analysis showed that significant factors associated with CRC screening participation in 2022 included being male (adjusted incidence risk ratio [aIRR] 1.07, 95% confidence interval [CI]; 1.00-1.14, p = 0.026), age in the 40s (aIRR 0.89, 95% CI; 0.81-0.97, p = 0.012) and 50s (aIRR 0.89, 95% CI; 0.82-0.98, p = 0.011), being unmarried (aIRR 0.88, 95% CI; 0.82-0.95, p = 0.001), and employment status such as self-employed (aIRR 0.86, 95% CI; 0.76-0.97, p = 0.012) or unemployed (aIRR 0.86, 95% CI; 0.81-0.92, p < 0.01). Having an FVC-19S score below 21 was also a factor (aIRR 0.95, 95% CI; 0.90-1.00, p = 0.032).
Although CRC screening rates increased from 2021 to 2022, a significant proportion of respondents still reported not undergoing screening, highlighting the importance of assessing the long-term impact of COVID-19 and identifying factors that make screening less accessible.
维持较高的参与率对于有效的结直肠癌（CRC）筛查至关重要。2019冠状病毒病（COVID-19）大流行给医疗机构带来了巨大负担，阻碍了CRC筛查工作。然而，长期大流行对CRC筛查的影响仍不清楚。
我们分析了2021年9月和2022年日本COVID-19与社会互联网调查的数据，以研究过去一年中CRC筛查的参与情况。我们还评估了2022年CRC筛查参与情况与参与状态、未来筛查意向、背景特征以及使用2021年调查中的2019冠状病毒病恐惧量表（FVC-19S）测量的对COVID-19的焦虑之间的关联。
在13261名受访者中，40.5%报告在2021年接受了CRC筛查，而在2022年这一比例为48.7%。多变量泊松回归分析显示，与2022年CRC筛查参与相关的显著因素包括男性（调整后的发病风险比[aIRR]为1.07，95%置信区间[CI]：1.00-1.14，p = 0.026）、40多岁（aIRR 0.89，95%CI：0.81-0.97，p = 0.012）和50多岁（aIRR 0.89，95%CI：0.82-0.98，p = 0.011）、未婚（aIRR 0.88，95%CI：0.82-0.95，p = 0.001）以及自雇（aIRR 0.86，95%CI：0.76-0.97，p = 0.012）或失业（aIRR 0.86，95%CI：0.81-0.92，p < 0.01）等就业状态。FVC-19S得分低于21也是一个因素（aIRR 0.95，95%CI：0.90-1.00，p = 0.032）。
尽管从2021年到2022年CRC筛查率有所提高，但仍有相当比例的受访者报告未接受筛查，这凸显了评估COVID-19的长期影响以及确定使筛查难以进行的因素的重要性。
